T2 Biosystems Obtains $40,000,000 Series E Funding

  • Feed Type
  • Date
    3/28/2013
  • Company Name
    T2 Biosystems
  • Mailing Address
    101 Hartwell Avenue Lexington, MA 02421
  • Company Description
    T2 Biosystems is a newly formed diagnostics company ushering in a new wave of innovative products to improve medical decision-making and treatment. Our proprietary biosensor technology was invented by a team of world-renowned scientists at MIT and Massachusetts General Hospital. Using this technology, we are developing a range of diagnostic products to impact a variety of health care settings; from centralized testing laboratories to point of care.
  • Website
    http://www.t2biosystems.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,000,000
  • Transaction Round
    Series E
  • Proceeds Purposes
    The Company also intends to use the proceeds to complete development of additional sepsis diagnostic panels and to advance and expand its research and development of other molecular, immunodiagnostic and hemostasis assays.
  • M&A Terms
  • Venture Investor
    Goldman Sachs
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Polaris Partners
  • Venture Investor
    Aisling Capital
  • Venture Investor
    Flybridge Capital Partners
  • Venture Investor
    Physic Ventures
  • Venture Investor
    Arcus Ventures
  • Venture Investor
    Partners HealthCare System
  • Venture Investor
    WS Investment

By posting a comment, you agree to our terms and conditions.